KAO JOHN E 4
4 · Alignment Healthcare, Inc. · Filed Jun 12, 2026
Research Summary
AI-generated summary of this filing
Alignment Healthcare (ALHC) CEO John Kao Sells Shares
What Happened
- John E. Kao, CEO of Alignment Healthcare, sold a total of 298,000 shares in open-market transactions on June 10, 2026. The sales were reported as two blocks: 74,936 shares at a weighted-average price of $19.65 (reported proceeds $1,472,350) and 223,064 shares at a weighted-average price of $20.60 (reported proceeds $4,594,271). Total proceeds reported: $6,066,621. These were outright sales (not purchases or option exercises).
Key Details
- Transaction dates: June 10, 2026; Form 4 filed June 12, 2026 (timely).
- Prices: weighted averages reported as $19.65 (first block) and $20.60 (second block).
- First block sold at prices ranging $19.12–$20.11 (per filing footnote).
- Second block sold at prices ranging $20.12–$20.89 (per filing footnote).
- Total shares sold: 298,000; total proceeds ≈ $6.07 million.
- Ownership/holdings note: footnotes indicate a transfer of 176,125 shares from Mr. Kao to the JEK Trust (dated Feb 8, 2021); the filing’s balance column reflects that transfer and that some securities are held by the JEK Trust.
- 10b5-1 plan: sales were executed under a Rule 10b5-1 trading plan adopted November 21, 2025 (footnote).
- Filing timeliness: reported within two days of the transactions (no late filing indicated).
Context
- These transactions are sales under a pre-established 10b5-1 plan, which allows insiders to trade according to a pre-set schedule; such sales are often routine and do not, by themselves, indicate the insider’s current view of the company’s prospects.
- The filing discloses weighted-average prices and price ranges; the reporting person offers to provide the exact per-price breakdown on request to the company, shareholders, or the SEC staff.
Insider Transaction Report
Form 4
KAO JOHN E
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
[F1][F2][F3][F4]2026-06-10$19.65/sh−74,936$1,472,350→ 1,609,830 total(indirect: See Footnote) - Sale
Common Stock
[F1][F5][F3][F4]2026-06-10$20.60/sh−223,064$4,594,271→ 1,386,766 total(indirect: See Footnote)
Holdings
- 1,608,743
Common Stock
[F3]
Footnotes (5)
- [F1]Date of Rule 10b5-1 plan adoption: 11/21/2025
- [F2]The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.12 to $20.11. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
- [F3]Balances in column 5 reflect the transfer of 176,125 shares held directly by Mr. Kao to the JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.
- [F4]Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.
- [F5]The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.12 to $20.89. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
Signature
/s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao|2026-06-12